A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known […]

This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn’s disease and answered the […]

[iframe_loader type=’iframe’ width=’100%’ height=’600′ frameborder=’0′ scrolling=’no’ src=’/wp-content/uploads/articulate_uploads/IBD-Benefits-and-Risk-Assesment-Tool4/story.html’]   This e-learning tool was made possible due to an unrestricted educational grant from Pfizer Canada